Kala Bio (KALA) Total Non-Current Liabilities (2016 - 2025)
Kala Bio (KALA) posted Total Non-Current Liabilities of $1.11 million for Q3 2025, down 95.2% from $23.35 million a year earlier and down 95.2% from the prior quarter.
Powered by 
Analysis
Kala Bio (KALA) Total Non-Current Liabilities (2016 - 2025) Analysis & Trends
At the end of FY2024, Kala Bio's Total Non-Current Liabilities came in at $26.2 million, down 34.7% from FY2023.
- Annual Total Non-Current Liabilities has declined for five consecutive years, with a five-year compound annual growth rate of -23.5% (FY2019 to FY2024).
- In prior years, Kala Bio's Total Non-Current Liabilities was $40.1 million in FY2023 (-4.9%), $42.16 million in FY2022 (-50.5%), $85.2 million in FY2021 (-14.3%) and $99.39 million in FY2020 (-0.5%).
- The Q3 2025 figure stands as the lowest quarterly Total Non-Current Liabilities in data going back to Q4 2016.
- On a year-over-year basis, Total Non-Current Liabilities has declined in each of the last 16 quarters, with an average decline of 34.4% over the last eight quarters.
- The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q3 2021, with growth of 5.7%; the weakest was Q3 2025, with a decline of 95.2%.
- According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $23.24 million (Q2 2025), $19.57 million (Q1 2025) and $26.2 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Kala Bio | 6.57 Mn | 6.57 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 1.11 Mn |
| Jun 30, 2025 | 23.24 Mn |
| Mar 31, 2025 | 19.57 Mn |
| Dec 31, 2024 | 26.20 Mn |
| Sep 30, 2024 | 23.35 Mn |
| Jun 30, 2024 | 28.70 Mn |
| Mar 31, 2024 | 34.49 Mn |
| Dec 31, 2023 | 40.10 Mn |
| Sep 30, 2023 | 39.60 Mn |
| Jun 30, 2023 | 39.16 Mn |
| Mar 31, 2023 | 38.50 Mn |
| Dec 31, 2022 | 42.16 Mn |
| Sep 30, 2022 | 46.43 Mn |
| Jun 30, 2022 | 83.64 Mn |
| Mar 31, 2022 | 84.10 Mn |
| Dec 31, 2021 | 85.20 Mn |
| Sep 30, 2021 | 105.15 Mn |
| Jun 30, 2021 | 105.12 Mn |
| Mar 31, 2021 | 100.05 Mn |
| Dec 31, 2020 | 99.39 Mn |
API Access
Kala Bio Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=KALA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "KALA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=KALA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();